EUCTR2005-002371-33-DE进行中（未招募）不适用
Finasterid-unterstützte Diagnostik des Prostatakarzinoms bei Patienten mit BPH
rologische Partnerschaft0 个研究点开始时间: 2005年12月27日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •- patients with elevated serum-PSA value
- •- Negative biopsy (min. sixfold), max. 2-12 months prior to inclusion
- •- Existence of enlargement of the prostate (>25 ml)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- former or current use of 5-alpha reductase inhibitors
- •- proof of prostate cancer
- •- acute prostatitis
研究者
相似试验
已完成
不适用
Dutasteride for biopsy-negative benign prostate hyperplasia - effects on cancer detection and aging male symptomsbiopsy-negative benign prostate hyperplasiaJPRN-UMIN000005288Department of Urology, University of Tokyo Hospital40
招募中
2 期
Diagnostic Performance of Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography (PET/CT) Imaging for Pre-operative Lymph Node Assessment in Intermediate and High-risk Nonmetastasic Prostate CancerProstate Cancer2024-516319-25-00Centre Hospitalier Regional Et Universitaire De Brest159
招募中
Unknown
Detection of clinically significant prostate cancer with MRI-TRUS fusion image-guided biopsy: comparison of the evaluation system (PI-RADS category vs. PI-RADS + US evalutaion)Suspected prostate cancerJPRN-UMIN000050631Tokai University80
招募中
不适用
A decision aid for the treatment of Benign Prostatic HyperplasiaDA BPHNL-OMON27217200
已完成
2 期
Phase IIa Study of F-1311 in Patients with Prostate CancerProstate cancerJPRN-jRCT2080222723PDRadiopharma Inc.15